Company news
02 November 2011
Alkor Bio represent the new diagnostic kit's line for Real-Time PCR analysis at the "Modern Hematology. Problems and Solutions" conference in Moscow
On the 2-3 of November biotechnological company from Saint-Petersburg- Alkor Bio- for the first time presented new diagnostic kit’s line for Real-Time PCR analysis in Moscow at the V theoretical and practical conference «Modern Hematology. Problems and Solutions». All the latest developments of the Alkor Bio for molecular genetic diagnostics: «TromboGENE-RT» (aimed for detection of hereditary thrombosis and determination of risk of the development of deep vein thrombosis as well as pulmonary thromboembolism); «PharmacoGENE- CYP2C9» and «PharmacoGENE- VKORC1» (the kits complement each other and are aimed for determination of the individual susceptibility for indirect anticoagulants); «PharmacoGENE- CYP2C19» (aimed for determination of a wide specter of drugs, which’s main isozym of metabolism is CYP2C19) were presented at the companies stand.